1. Home
  2. KRYS vs PBF Comparison

KRYS vs PBF Comparison

Compare KRYS & PBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • PBF
  • Stock Information
  • Founded
  • KRYS 2015
  • PBF 2008
  • Country
  • KRYS United States
  • PBF United States
  • Employees
  • KRYS N/A
  • PBF N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • PBF Integrated oil Companies
  • Sector
  • KRYS Health Care
  • PBF Energy
  • Exchange
  • KRYS Nasdaq
  • PBF Nasdaq
  • Market Cap
  • KRYS 3.6B
  • PBF 3.1B
  • IPO Year
  • KRYS 2017
  • PBF 2012
  • Fundamental
  • Price
  • KRYS $133.05
  • PBF $23.83
  • Analyst Decision
  • KRYS Strong Buy
  • PBF Hold
  • Analyst Count
  • KRYS 8
  • PBF 13
  • Target Price
  • KRYS $211.13
  • PBF $24.25
  • AVG Volume (30 Days)
  • KRYS 320.8K
  • PBF 3.4M
  • Earning Date
  • KRYS 08-04-2025
  • PBF 07-31-2025
  • Dividend Yield
  • KRYS N/A
  • PBF 4.61%
  • EPS Growth
  • KRYS 109.01
  • PBF N/A
  • EPS
  • KRYS 4.16
  • PBF N/A
  • Revenue
  • KRYS $333,448,000.00
  • PBF $31,536,100,000.00
  • Revenue This Year
  • KRYS $44.05
  • PBF N/A
  • Revenue Next Year
  • KRYS $46.15
  • PBF $7.58
  • P/E Ratio
  • KRYS $31.77
  • PBF N/A
  • Revenue Growth
  • KRYS 247.53
  • PBF N/A
  • 52 Week Low
  • KRYS $122.80
  • PBF $13.62
  • 52 Week High
  • KRYS $219.34
  • PBF $48.20
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 44.16
  • PBF 65.40
  • Support Level
  • KRYS $127.99
  • PBF $17.53
  • Resistance Level
  • KRYS $143.20
  • PBF $24.96
  • Average True Range (ATR)
  • KRYS 4.23
  • PBF 1.33
  • MACD
  • KRYS 1.01
  • PBF 0.46
  • Stochastic Oscillator
  • KRYS 44.48
  • PBF 84.79

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About PBF PBF Energy Inc.

PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines and storage facilities. The Logistics segment consists solely of PBFX's operations.

Share on Social Networks: